Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential
Summary
The Cluster Health is under Pillar 2 of Horizon Europe. Its role is to advance knowledge and capabilities, improve understanding of health and diseases, develop innovative methodological and technological solutions to better manage health and diseases, as well as to design sustainable approaches for the digital transformation and delivery of integrated, person-centred and equitable health and care services.
Programme Name
Programme Description
Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
Call
Detailed Call Description
Proposals should provide innovative approaches with the aim to diversify and accelerate the global pandemic preparedness research and development pipeline for emerging and re-emerging viral infections, and to strengthen the role of the EU in therapeutic research and development, and therefore contributing to the work of the European Health Emergency Preparedness and Response Authority (HERA).
Proposals should address several of the following areas:
- Identification of key antigenic targets for the priority pathogens as mentioned above.
- Improvement or, if necessary, establishment of animal models for the testing of vaccine candidates where alternative models are not available.
- Characterisation of the immunogenicity of antigenic targets in appropriate animal or alternative models and in pre-clinical tests.
- Inclusion, if possible, of proof-of-concept studies in humans of the vaccine candidate.
Applicants envisaging to include clinical studies should provide details of their clinical studies in the dedicated annex using the template provided in the submission system.
Financing percentage by EU or other bodies / Level of Subsidy or Loan
100%
Contribution per project: between €7,00 and €8,00 million
Eligibility For Participation Notes
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
Programme Category
EU Competitive ProgrammesTotal Budget
€ 50,00 millionThematic Categories
- Health
- Research, Technological Development and Innovation
Eligibility for Participation
- Associations
- Other Beneficiaries
- Private Bodies
- Researchers/Research Centers/Institutions
- State-owned Enterprises
- Training Centres
Call Opening Date
12/01/2023Call Closing Date
13/04/2023National Contact Point(s)
Research and Innovation Foundation
29a Andrea Michalakopoulou, 1075 Nicosia
P.O.Box 23422, 1683 Nicosia
Telephone: +357 22205000
Email Address: support@research.org.cy
Website: https://www.research.org.cy/en/
Contact Persons:
George Christou
Scientific Officer
Email: gchristou@research.org.cy
Ioannis Theodorou
Scientific Officer
Telephone: +357 22 205 038
Contact Email: itheodorou@research.org.cy
(Publish Date: 08/02/2023-for internal use only)
EU Contact Point
European Commission, Directorate-General for Research and Innovation
https://ec.europa.eu/info/departments/research-and-innovation_en#contact